Impact of quality as well as quantity of skeletal muscle on outcomes after liver transplantation

Intramuscular fat accumulation has come to be associated with loss of muscle strength and function, one of the components of sarcopenia. However, the impact of preoperative quality of skeletal muscle on outcomes after living donor liver transplantation (LDLT) is unclear. The present study evaluated the intramuscular adipose tissue content (IMAC) and psoas muscle mass index (PMI) in 200 adult patients undergoing LDLT at our institution between January 2008 and October 2013. Correlations of IMAC with other factors, overall survival rates in patients classified according to IMAC or PMI, and risk factors for poor survival after LDLT were analyzed. IMAC was significantly correlated with age (r = 0.229, P = 0.03) and PMI (r = −0.236, P = 0.02) in males and with age (r = 0.349, P < 0.001) and branched‐chain amino acid (BCAA)‐to‐tyrosine ratio (r = −0.250, P = 0.01) in females. The overall survival rates in patients with high IMAC or low PMI were significantly lower than those for patients with normal IMAC or PMI (P < 0.001, P < 0.001, respectively). Multivariate analysis showed that high IMAC [odds ratio (OR) = 3.898, 95% confidence interval (CI) = 2.025‐7.757, P < 0.001] and low PMI (OR = 3.635, 95% CI = 1.896‐7.174, P < 0.001) were independent risk factors for death after LDLT. In conclusion, high IMAC and low PMI were closely involved with posttransplant mortality. Preoperative quality and quantity of skeletal muscle could be incorporated into new selection criteria for LDLT. Perioperative nutritional therapy and rehabilitation could be important for good outcomes after LDLT. Liver Transpl 20:1413‐1419, 2014. © 2014 AASLD.

[1]  S. Toda,et al.  Age-related fat deposition in multifidus muscle could be a marker for nonalcoholic fatty liver disease , 2010, Journal of Gastroenterology.

[2]  T. Kiuchi,et al.  SURGERY‐RELATED MORBIDITY IN LIVING DONORS OF RIGHT‐LOBE LIVER GRAFT: LESSONS FROM THE FIRST 200 CASES , 2003, Transplantation.

[3]  V. Vilgrain,et al.  Prognostic value of muscle atrophy in cirrhosis using psoas muscle thickness on computed tomography. , 2014, Journal of hepatology.

[4]  Michael A. Choti,et al.  Impact of Sarcopenia on Outcomes Following Resection of Pancreatic Adenocarcinoma , 2012, Journal of Gastrointestinal Surgery.

[5]  T. Manini,et al.  Longitudinal study of muscle strength, quality, and adipose tissue infiltration. , 2009, The American journal of clinical nutrition.

[6]  T. Yamanaka,et al.  Sarcopenia as a predictor of prognosis in patients following hepatectomy for hepatocellular carcinoma , 2013, The British journal of surgery.

[7]  K. Campbell,et al.  TNF-alpha acts via TNFR1 and muscle-derived oxidants to depress myofibrillar force in murine skeletal muscle. , 2008, Journal of applied physiology.

[8]  Robert Ross,et al.  Low Relative Skeletal Muscle Mass (Sarcopenia) in Older Persons Is Associated with Functional Impairment and Physical Disability , 2002, Journal of the American Geriatrics Society.

[9]  Skeletal muscle fat infiltration: Impact of age, inactivity, and exercise , 2010, The journal of nutrition, health & aging.

[10]  C. Lutz,et al.  Sarcopenia, obesity, and natural killer cell immune senescence in aging: Altered cytokine levels as a common mechanism , 2012, Aging.

[11]  Hirokazu Takahashi,et al.  Severity of non‐alcoholic steatohepatitis is associated with substitution of adipose tissue in skeletal muscle , 2013, Journal of gastroenterology and hepatology.

[12]  M. Sawyer,et al.  Muscle wasting is associated with mortality in patients with cirrhosis. , 2012, Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association.

[13]  S. Kritchevsky,et al.  Leg Muscle Mass and Composition in Relation to Lower Extremity Performance in Men and Women Aged 70 to 79: The Health, Aging and Body Composition Study , 2002, Journal of the American Geriatrics Society.

[14]  J. Baeyens,et al.  European working group on sarcopenia in older people. Sarcopenia: European consensus on definition and diagnosis: report of the European working group on sarcopenia in older people , 2010 .

[15]  S. Rubin,et al.  Higher inflammatory marker levels in older persons: associations with 5-year change in muscle mass and muscle strength. , 2009, The journals of gerontology. Series A, Biological sciences and medical sciences.

[16]  R Ross,et al.  Skeletal muscle attenuation determined by computed tomography is associated with skeletal muscle lipid content. , 2000, Journal of applied physiology.

[17]  Herbert Tilg,et al.  Adipocytokines: mediators linking adipose tissue, inflammation and immunity , 2006, Nature Reviews Immunology.

[18]  K Ogawa,et al.  Impact of Sarcopenia on Survival in Patients Undergoing Living Donor Liver Transplantation , 2013, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.

[19]  Mark G van Vledder,et al.  Sarcopenia negatively impacts short-term outcomes in patients undergoing hepatic resection for colorectal liver metastasis. , 2011, HPB : the official journal of the International Hepato Pancreato Biliary Association.

[20]  H. Shimada,et al.  Outcomes of Adult-to-Adult Living Donor Liver Transplantation: A Single Institution's Experience With 335 Consecutive Cases , 2007, Annals of surgery.

[21]  S. Uemoto,et al.  Right lobe graft in living donor liver transplantation. , 1999, Transplantation.

[22]  M. Sawyer,et al.  Sarcopenia as a Prognostic Index of Nutritional Status in Concurrent Cirrhosis and Hepatocellular Carcinoma , 2013, Journal of clinical gastroenterology.

[23]  A. Schousboe,et al.  Branched-chain amino acids increase arterial blood ammonia in spite of enhanced intrinsic muscle ammonia metabolism in patients with cirrhosis and healthy subjects. , 2011, American journal of physiology. Gastrointestinal and liver physiology.

[24]  S. Fujita,et al.  RIGHT LOBE GRAFT IN LIVING DONOR LIVER TRANSPLANTATION 1,2 , 2000 .

[25]  P. Ott,et al.  Branched-chain amino acids and muscle ammonia detoxification in cirrhosis , 2013, Metabolic Brain Disease.

[26]  Douglas E Schaubel,et al.  Sarcopenia and mortality after liver transplantation. , 2010, Journal of the American College of Surgeons.

[27]  Y. Wu,et al.  Prevalence of Sarcopenia Estimated Using a Bioelectrical Impedance Analysis Prediction Equation in Community‐Dwelling Elderly People in Taiwan , 2008, Journal of the American Geriatrics Society.

[28]  M. V. Van Vledder,et al.  Body composition and outcome in patients undergoing resection of colorectal liver metastases , 2012, The British journal of surgery.

[29]  M. Holeček Branched-chain amino acids and ammonia metabolism in liver disease: therapeutic implications. , 2013, Nutrition.